202 related articles for article (PubMed ID: 34392914)
1. PET Imaging for Hematologic Malignancies.
Hughes NM; Jacene HA
Radiol Clin North Am; 2021 Sep; 59(5):705-723. PubMed ID: 34392914
[TBL] [Abstract][Full Text] [Related]
2. MRI and PET/MRI in hematologic malignancies.
Mayerhoefer ME; Archibald SJ; Messiou C; Staudenherz A; Berzaczy D; Schöder H
J Magn Reson Imaging; 2020 May; 51(5):1325-1335. PubMed ID: 31260155
[TBL] [Abstract][Full Text] [Related]
3. Evolving Role of PET-Based Novel Quantitative Techniques in the Management of Hematological Malignancies.
Raynor WY; Zadeh MZ; Kothekar E; Yellanki DP; Alavi A
PET Clin; 2019 Jul; 14(3):331-340. PubMed ID: 31084773
[TBL] [Abstract][Full Text] [Related]
4. Breast involvement in hematological malignancies on
García Vicente AM; Cabero Becerra MA; Pérez Rodriguez G; Romero Macías JR; Soriano Castrejón Á
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2022; 41(1):43-44. PubMed ID: 34991835
[No Abstract] [Full Text] [Related]
5. Critical role of PET/CT-based novel quantitative techniques for assessing global disease activity in multiple myeloma and other hematological malignancies: why it is time to abandon reliance on examining focal lesions.
Taghvaei R; Zadeh MZ; Werner TJ; Alavi A
Eur Radiol; 2021 Jan; 31(1):149-151. PubMed ID: 33125560
[No Abstract] [Full Text] [Related]
6. FDG PET/CT manifestations of hematopoietic malignancies of the breast.
Ginat DT; Puri S
Acad Radiol; 2010 Aug; 17(8):1026-30. PubMed ID: 20547460
[TBL] [Abstract][Full Text] [Related]
7. Blastic Plasmacytoid Dendritic Cell Neoplasm Evaluated by FDG PET/CT.
Li ZG; Mu HY
Clin Nucl Med; 2017 Jul; 42(7):551-552. PubMed ID: 28394841
[TBL] [Abstract][Full Text] [Related]
8. PET Imaging for Breast Cancer.
Fowler AM; Cho SY
Radiol Clin North Am; 2021 Sep; 59(5):725-735. PubMed ID: 34392915
[TBL] [Abstract][Full Text] [Related]
9. Overview and recent advances in PET/CT imaging in lymphoma and multiple myeloma.
Zanoni L; Mattana F; Calabrò D; Paccagnella A; Broccoli A; Nanni C; Fanti S
Eur J Radiol; 2021 Aug; 141():109793. PubMed ID: 34148014
[TBL] [Abstract][Full Text] [Related]
10. FDG-PET/CT Variants and Pitfalls in Haematological Malignancies.
Pilkington P; Lopci E; Adam JA; Kobe C; Goffin K; Herrmann K
Semin Nucl Med; 2021 Nov; 51(6):554-571. PubMed ID: 34272037
[TBL] [Abstract][Full Text] [Related]
11. 18F-FDG-PET/CT Imaging for Gastrointestinal Malignancies.
Howard BA; Wong TZ
Radiol Clin North Am; 2021 Sep; 59(5):737-753. PubMed ID: 34392916
[TBL] [Abstract][Full Text] [Related]
12. Present and future role of FDG-PET/CT imaging in the management of breast cancer.
Kitajima K; Miyoshi Y
Jpn J Radiol; 2016 Mar; 34(3):167-80. PubMed ID: 26733340
[TBL] [Abstract][Full Text] [Related]
13. [Hemato-oncological imaging : Importance of hybrid procedures].
Mayerhoefer ME; Haug A
Radiologe; 2016 Jul; 56(7):597-604. PubMed ID: 27335021
[TBL] [Abstract][Full Text] [Related]
14. Musculoskeletal Imaging Findings of Hematologic Malignancies.
Navarro SM; Matcuk GR; Patel DB; Skalski M; White EA; Tomasian A; Schein AJ
Radiographics; 2017; 37(3):881-900. PubMed ID: 28388273
[TBL] [Abstract][Full Text] [Related]
15. PET Imaging for Head and Neck Cancers.
Marcus C; Sheikhbahaei S; Shivamurthy VKN; Avey G; Subramaniam RM
Radiol Clin North Am; 2021 Sep; 59(5):773-788. PubMed ID: 34392918
[TBL] [Abstract][Full Text] [Related]
16. DaPeCa-7: comparative assessment of fluorodeoxyglucose positron emission tomography/computed tomography (CT) and conventional diagnostic CT in diagnosis of lymph node metastases, distant metastases and incidental findings in patients with invasive penile cancer.
Jakobsen JK; Frahm Nielsen T; Ipsen P; Albrecht-Beste E; Cardoso Costa J; Alslev L; Predbjørn Krarup K; Grønkaer Toft B; Høyer S; Bouchelouche K; Bjerggaard Jensen J
BJU Int; 2021 Feb; 127(2):254-262. PubMed ID: 33448605
[TBL] [Abstract][Full Text] [Related]
17. Access, knowledge and experience with fluorodeoxyglucose positron emission tomography/computed tomography in infection management: a survey of Australia and New Zealand infectious diseases physicians and microbiologists.
Douglas AP; Thursky KA; Worth LJ; Harrison SJ; Hicks RJ; Slavin MA
Intern Med J; 2019 May; 49(5):615-621. PubMed ID: 30230669
[TBL] [Abstract][Full Text] [Related]
18. FDG-PET imaging in hematological malignancies.
Valls L; Badve C; Avril S; Herrmann K; Faulhaber P; O'Donnell J; Avril N
Blood Rev; 2016 Jul; 30(4):317-31. PubMed ID: 27090170
[TBL] [Abstract][Full Text] [Related]
19. The role of 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) in assessment of complex invasive fungal disease and opportunistic co-infections in patients with acute leukemia prior to allogeneic hematopoietic cell transplant.
Longhitano A; Alipour R; Khot A; Bajel A; Antippa P; Slavin M; Thursky K
Transpl Infect Dis; 2021 Jun; 23(3):e13547. PubMed ID: 33338319
[TBL] [Abstract][Full Text] [Related]
20. Positron Emission Tomography (PET) Radiopharmaceuticals in Multiple Myeloma.
Sachpekidis C; Goldschmidt H; Dimitrakopoulou-Strauss A
Molecules; 2019 Dec; 25(1):. PubMed ID: 31905752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
